Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44CA065434-03
Application #
2108417
Study Section
Medicinal Chemistry Study Section (MCHA)
Project Start
1995-02-17
Project End
1997-08-16
Budget Start
1996-02-17
Budget End
1997-08-16
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Moravek Biochemicals, Inc.
Department
Type
DUNS #
City
Brea
State
CA
Country
United States
Zip Code
92821

  Publications

Hurwitz, S J; Ma, L; Eleuteri, A et al. (2000) Cellular pharmacology of the D- and L-enantiomers of beta-5-o-carboranyl-2'-deoxyuridine. Nucleosides Nucleotides Nucleic Acids 19:691-702
Mourier, N S; Eleuteri, A; Hurwitz, S J et al. (1999) Enantioselective synthesis and biological evaluation of 5-o-carboranyl pyrimidine nucleosides. Bioorg Med Chem 7:2759-66
Lesnikowski, Z J; Fulcrand, G; Lloyd Jr, R M et al. (1996) Carboranyl oligonucleotides. 3. Biochemical properties of oligonucleotides containing 5-(o-carboranyl-1-yl)-2'-deoxyuridine. Biochemistry 35:5741-6